Phenotypical difference in deamination of cytarabine is not evident in induction therapy for acute myeloid leukemia

Mikkel Krogh-Madsen; Steen Honore' Hansen; Morten Krogh  Jensen; Ove Juul  Nielsen; Hanna Søndergaard Jensen; Per Gustaf Hartvig Honoré

doi:10.1136/ejhpharm-2012-000270

Phenotypical difference in deamination of cytarabine is not evident in induction therapy for acute myeloid leukemia

Mikkel Krogh-Madsen
, Steen Honore' Hansen
, Morten Krogh Jensen
, Ove Juul Nielsen
, Hanna Søndergaard Jensen
, Per Gustaf Hartvig Honoré

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	European Journal of Hospital Pharmacy - Science and Practice
Vol/bind	20
Udgave nummer	3
Sider (fra-til)	185-188
DOI	https://doi.org/10.1136/ejhpharm-2012-000270
Status	Udgivet - 2013

Adgang til dokumentet

10.1136/ejhpharm-2012-000270

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

Phenotypical difference in deamination of cytarabine is not evident in induction therapy for acute myeloid leukemia. / Krogh-Madsen, Mikkel; Hansen, Steen Honore'; Jensen, Morten Krogh et al.
I: European Journal of Hospital Pharmacy - Science and Practice, Bind 20, Nr. 3, 2013, s. 185-188.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{91e41e69097a45bf8ad349dcfc14e1e3,

title = "Phenotypical difference in deamination of cytarabine is not evident in induction therapy for acute myeloid leukemia",

author = "Mikkel Krogh-Madsen and Hansen, \{Steen Honore'\} and Jensen, \{Morten Krogh\} and Nielsen, \{Ove Juul\} and Jensen, \{Hanna S{\o}ndergaard\} and Honor{\'e}, \{Per Gustaf Hartvig\}",

year = "2013",

doi = "10.1136/ejhpharm-2012-000270",

language = "English",

volume = "20",

pages = "185--188",

journal = "European Journal of Hospital Pharmacy - Science and Practice",

issn = "2030-3769",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Phenotypical difference in deamination of cytarabine is not evident in induction therapy for acute myeloid leukemia

AU - Krogh-Madsen, Mikkel

AU - Hansen, Steen Honore'

AU - Jensen, Morten Krogh

AU - Nielsen, Ove Juul

AU - Jensen, Hanna Søndergaard

AU - Honoré, Per Gustaf Hartvig

PY - 2013

Y1 - 2013

U2 - 10.1136/ejhpharm-2012-000270

DO - 10.1136/ejhpharm-2012-000270

M3 - Journal article

SN - 2030-3769

SN - 2047-9964

VL - 20

SP - 185

EP - 188

JO - European Journal of Hospital Pharmacy - Science and Practice

JF - European Journal of Hospital Pharmacy - Science and Practice

IS - 3

ER -